论文部分内容阅读
据ＡｍＪＨｅａｌｔｈＳｙｓｔＰｈａｒｍ（１９９８，５５：１４４０）载，１９９８年５月，ＦＤＡ同意上市２种静脉输注的血小板糖蛋白Ⅱｂ／Ⅲａ受体拮抗剂替罗非班（ｔｉｒｏｆｉｂａｎ）及埃替非巴肽（ｅｐｔｉｆｉｂａｔｉｄｅ）。这类药物的第一个产品是阿昔单抗...
According to AmJHealth-SystPharm (1998, 55: 1440), in May 1998, the FDA agreed to list two intravenous infusion of platelet glycoprotein IIb / IIIa receptor antagonists tirofiban and eptifibatide (Eptifibatide). The first product of these drugs is abciximab ...